Bedminster, NJ, United States of America

David E Moller

USPTO Granted Patents = 5 

Average Co-Inventor Count = 7.6

ph-index = 5

Forward Citations = 120(Granted Patents)


Location History:

  • Bedminster, NJ (US) (1998 - 2000)
  • Watchung, NJ (US) (2004)

Company Filing History:


Years Active: 1998-2004

Loading Chart...
5 patents (USPTO):Explore Patents

Title: **David E. Moller: Innovator in Biopharmaceuticals**

Introduction

David E. Moller is a distinguished inventor based in Bedminster, NJ, USA, with a prolific output of five patents to his name. His contributions to the field of biopharmaceuticals focus primarily on innovative methods and compounds for addressing significant health conditions, particularly those related to metabolic disorders.

Latest Patents

Among his latest innovations, Moller has developed methods for assays targeting nuclear receptor agonists and antagonists through fluorescence resonance energy transfer (FRET). This method allows for the identification of specific nuclear receptor interactions in a simple, rapid, and cost-effective manner. Additionally, he has worked on benzisoxazole-derived antidiabetic compounds, which include acetylphenols beneficial for tackling obesity and diabetes. These compounds are aimed at lowering triglyceride and cholesterol levels, increasing gut motility, and combating atherosclerosis.

Career Highlights

David Moller has made significant strides in his career as a scientist and inventor at Merck & Company, Inc., a leading player in the global pharmaceutical industry. His research and innovations have had a profound impact on the development of therapeutics related to metabolic diseases, further solidifying his reputation in the biopharmaceutical community.

Collaborations

Throughout his career, Moller has collaborated closely with colleagues such as Gregory D. Berger and Joel Peter Berger. These partnerships have enabled fruitful exchanges of ideas and expertise, contributing to innovations that advance the field of medicine.

Conclusion

David E. Moller exemplifies the spirit of innovation required to tackle complex health issues. His recent patents not only pave the way for new therapeutic strategies but also highlight the importance of collaboration in scientific research. As he continues to work at Merck & Company, his contributions remain a vital part of the ongoing quest to improve public health through biopharmaceutical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…